论文部分内容阅读
目的探讨急性脑血管病早期高血糖调治范围及调治方法。方法急性脑血管病5316例病人被随机分入治疗组、对照1和2组。治疗组依据急性脑血管病后高血糖水平,早期静脉泵入胰岛素,加用益气调糖合剂。采用8+点法和5+点法监测血糖。对照组采用常规治疗方法。观察临床疗效和预后状况。结果治疗第10、30d,CSS评分,治疗组在治愈、显效、好转及总有效方面均明显高于对照1、2组(P<0.01),而在无效或恶化以及死亡方面明显低于对照1、2组(P<0.01)。对照1、2组预后均较治疗组差(P<0.01)。结论急性脑血管病后高血糖的目标血糖,在应激性者应为7.00～7.50mmol/L,糖尿病性为MBGC+1.50～2.00mmol/L。8+点法和5+点法可以很好地监测血糖水平。此调治技术能够使高血糖恒定在理想的目标血糖水平。
Objective To explore the early treatment of acute cerebrovascular disease hyperglycemia and treatment methods. Methods 5316 patients with acute cerebrovascular disease were randomly divided into treatment group and control group 1 and 2. Treatment group based on acute cerebrovascular disease after high blood sugar levels, early intravenous infusion of insulin, plus qi tonic mixture. Using 8 + point method and 5 + point method to monitor blood sugar. Control group using conventional treatment. To observe the clinical efficacy and prognosis. Results On the 10th and 30th day of treatment, CSS score was significantly higher in treatment group than in control group 1 and 2 group (P <0.01), but significantly lower than control 1 in ineffectiveness, exacerbation and death , Two groups (P <0.01). The control group 1 and group 2 had worse prognosis than the treatment group (P <0.01). Conclusion The target blood glucose of hyperglycemia after acute cerebrovascular disease should be 7.00-7.50mmol / L for stress and MBGC + 1.50-2.00mmol / L for diabetes mellitus. The 8+ and 5+ points monitor blood sugar levels well. This conditioning technology enables hyperglycemia to be constant at the desired target blood glucose level.